Document Detail


Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.
MedLine Citation:
PMID:  19837434     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Although the effect of phosphodiesterase type 5 inhibitors on endothelial function in the systemic circulation has been extensively studied, its effect on penile endothelial function remains unexplored. Therefore, we evaluated the effect of daily sildenafil on penile endothelial function. MATERIALS AND METHODS: A total of 60 patients with erectile dysfunction were randomized blindly to daily placebo or 50 mg sildenafil for 4 weeks. Penile and forearm blood flow as well as endothelial function indices were measured at baseline and after 4 weeks using venoocclusive strain gauge plethysmography for both organs. Sequential changes in flow, maximal blood flow and area under the curve induced by reactive hyperemia after 5 minutes of transient ischemia were considered indices of endothelial function. RESULTS: There were 34 patients treated with sildenafil and 19 on placebo who completed the study. The general characteristics of both groups were comparable. Mean +/- SEM baseline penile blood flow was 6.2 +/- 1.4 and 7.0 +/- 0.6 ml/dl per minute for the placebo and sildenafil groups, respectively (p = 0.54). Baseline forearm blood flow was similar in both groups. At baseline penile AUC was 420 +/- 50 and 520 +/- 50 (p = 0.18), and in the forearm it was 445 +/- 40 and 410 +/- 40 (p = 0.45) for the placebo and sildenafil groups, respectively. After 4 weeks on the assigned drug penile blood flow increased to 11.2 +/- 2 ml/dl per minute in the sildenafil group (p = 0.02) and remained unchanged in the placebo group. After 4 weeks penile AUC increased to 720 +/- 65 in the sildenafil group (0.04) and remained unchanged in the placebo group. Placebo and sildenafil did not affect the indices of forearm endothelial function. CONCLUSIONS: Daily sildenafil significantly improves penile blood flow and penile endothelial function indices without causing any relevant systemic effects.
Authors:
Yoram Vardi; Boaz Appel; Yaron Ofer; Ilan Greunwald; Lior Dayan; Giris Jacob
Related Documents :
11400544 - Post-prandial lipaemia and endothelial function among healthy men.
1442584 - Impaired forearm vasodilation to hyperosmolal stimuli in patients with congestive heart...
10371794 - Local effects on the blood gas indices in diaphyseal forearm fractures.
6769454 - Acquired tolerance to dilator action of hydrallazine during oral administration.
12782194 - S1p3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-ph...
2773274 - Characterization of trypanosoma (trypanozoon) evansi from dromedary camels in kuwait by...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2009-10-17
Journal Detail:
Title:  The Journal of urology     Volume:  182     ISSN:  1527-3792     ISO Abbreviation:  J. Urol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-12     Completed Date:  2009-11-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2850-5     Citation Subset:  AIM; IM    
Affiliation:
Neurourology Unit, Rambam Medical Center and Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. yvardi@rambam.health.gov.il
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00297544
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Double-Blind Method
Endothelium, Vascular / drug effects*,  physiology*
Erectile Dysfunction / drug therapy*
Humans
Male
Middle Aged
Penis / blood supply*
Phosphodiesterase Inhibitors / administration & dosage,  pharmacology*
Piperazines / administration & dosage,  pharmacology*
Purines / administration & dosage,  pharmacology
Sulfones / administration & dosage,  pharmacology*
Chemical
Reg. No./Substance:
0/Phosphodiesterase Inhibitors; 0/Piperazines; 0/Purines; 0/Sulfones; 139755-83-2/sildenafil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer.
Next Document:  Safety and Tolerability of Solifenacin Add-on Therapy to alpha-Blocker Treated Men With Residual Urg...